Dr. Wael A. Jaber, MD

Dr. Jaber practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Jaber's NPI, 1437244910, was assigned on October 3, 2006. Dr. Jaber holds Ohio license 35075565J.

Dr. Jaber's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Jaber's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Jaber is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Jaber to 3 more hospitals, 2 clinical labs and 1 medical group, each named with a free account. Dr. Jaber's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jaber practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Jaber's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Jaber is licensed in Ohio.

CMS data shows 3,525 Medicare services from Dr. Jaber across 24 procedure codes in 2024, for 1,675 Medicare patients. Medicare paid $122,272 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,675 Medicare patients who saw Dr. Jaber in 2024. The largest group is 65 to 74, with 770 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jaber's median patient age at 66, with 39% women.

In 2024, Dr. Jaber wrote 2,230 Medicare Part D claims for 315 patients. 85% of them were for generic drugs. CMS names the drug for 2,067 of them, across 33 drugs with 11 or more claims each, at $580,411 in total drug cost. In 2023, CMS named 1,890 claims across 35 drugs.

Dr. Jaber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jaber as offering telehealth.

Dmand AI links 267 papers to Dr. Jaber, published from 2011 to 2025. 2021 was the busiest year, with 30. The most frequent topics are Myocardial Perfusion Imaging, Aortic Valve Stenosis and Atrial Fibrillation. Dr. Jaber has published most often in J Nucl Cardiol. Dr. Jaber's most frequent co-authors are Oussama M. Wazni, MD, Serge Charbel Harb, MD and Mazen A. Hanna, MD.

Dmand AI links Dr. Jaber to 1 clinical trial. Conditions studied include Amyloid Neuropathies and Amyloid Neuropathies, Familial.

CMS Open Payments shows 151 general payments to Dr. Jaber from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Boston Scientific Corporation paid the most, $86,617.